![Jason Coloma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Coloma
Amministratore Delegato presso
Maze Therapeutics, Inc.
Patrimonio netto: 7 M $ in data 31/07/2026
Profilo
Jason V.
Coloma is currently Chief Executive Officer & Director at Maze Therapeutics, Inc., Director at St. Anthony's Foundation, and Director at Braveheart Bio, Inc. since 2024.
Former roles include Independent Director at BioAge Labs, Inc. from 2021 to 2024, Chief Business Officer & Senior Vice President at Corvus Pharmaceuticals, Inc., and VP & Global Head-Roche Oncology Business at Roche Diagnostics Corp.
from 2008 to 2016.
Education includes a doctorate from the University of California, Berkeley, an undergraduate degree from the University of San Francisco, and an MBA from the Tuck School of Business at Dartmouth.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases 0,5% | 03/08/2026 | 276.007 ( 0,5% ) | 7 M $ | 31/07/2026 |
1,27% | 06/08/2026 | 1.100.456 ( 1,27% ) | 11 $ | 31/07/2026 |
Posizioni attive di Jason Coloma
| Società | Posizione | Inizio |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Amministratore Delegato | 01/07/2019 |
St. Anthony's Foundation
 St. Anthony's Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a social service organization which works to feed, cloth, heal and lift the spirits of people | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jason Coloma
| Società | Posizione | Fine |
|---|---|---|
| BIOAGE LABS, INC. | Direttore/Membro del Consiglio | 20/08/2024 |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Corporate Officer/Principal | 01/01/2016 |
| CORVUS PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | - |
Formazione di Jason Coloma
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Anthony's Foundation
St. Anthony's Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a social service organization which works to feed, cloth, heal and lift the spirits of people | Commercial Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
